首页 | 本学科首页   官方微博 | 高级检索  
     

化学发光法检测卵巢癌血清学人附睾蛋白46例临床分析
引用本文:刘刚,葛鑫. 化学发光法检测卵巢癌血清学人附睾蛋白46例临床分析[J]. 蚌埠医学院学报, 2011, 36(11): 1251-1252
作者姓名:刘刚  葛鑫
作者单位:1. 安徽省蚌埠市第三人民医院检验科, 233000;2. 蚌埠医学院第一附属医院检验科, 安徽蚌埠 233004
摘    要:目的:探讨人附睾蛋白4(human epididymis gene protein 4,HE4)对临床不同分期卵巢癌的诊断价值及是否优于癌抗原125(cancer antigen 125,CA125)肿瘤标志物。方法:采用全自动化学发光法分别检测46例卵巢癌组(其中早期9例、中期31例、晚期6例)、50例盆腔良性瘤组、50名健康女性对照组的HE4含量。结果:卵巢癌组HE4含量均明显高于盆腔良性肿瘤组和健康组(P<0.01);9例早期卵巢癌中的HE4阳性率达78%,而CA125阳性率55%,差异有统计学意义(P<0.05)。结论:HE4是诊断卵巢癌的一项特异性肿瘤标志物,且优于CA125,特别对早期卵巢癌的诊断具有重要意义。

关 键 词:卵巢肿瘤   化学发光法   人附睾蛋白4   癌抗原125
收稿时间:2011-04-29

Clinical analysis of Serum HE4 by chemiluminescence method in 46 patients with ovarian cancer
LIU Gang,GE Xin. Clinical analysis of Serum HE4 by chemiluminescence method in 46 patients with ovarian cancer[J]. Journal of Bengbu Medical College, 2011, 36(11): 1251-1252
Authors:LIU Gang  GE Xin
Affiliation:1. Department of Clinical Laboratory Science, Bengbu Third People's Hospital, Bengbu Anhui 233000;2. Department of Clinical Laboratory Science, The First Affiliated Hospital of Bengbu Medical College, Benbu Anhui 233004 China
Abstract:Objective:To explore the value of human epididymis protein 4(HE4) in diagnosis of ovarian cancer in different clinical stages,and determine whether HE4 is better than cancer antigen 125(CA125),another tumor marker of ovarian cancer.Methods:The serum HE4 levels in 46 patients with ovarian cancer(among them,the numbers of early,intermediate and terminal cancer were 9,31 and 6,respectively),50 patients with benign ovarian tumour and 50 healthy women were measured by automatic chemiluminescence method.Results:T...
Keywords:ovarian neoplasms  chemiluminescence method  human epididymis protein 4  cancer antigen 125  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号